Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salvage therapy.

Simon Collins

    BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
    |April 15, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Salvage therapy is a critical approach for individuals with HIV whose initial treatments have failed. This therapy aims to manage treatment-experienced patients facing complex drug resistance challenges.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    How Angular Mismatch and Surface Topography in Modular Head-Stem Taper Junctions in Total Hip Replacements Affects Fretting-Corrosion and Motion Under Uni-Axial Loading.

    Sensors (Basel, Switzerland)·2026
    Same author

    Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

    The lancet. HIV·2026
    Same author

    Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

    The lancet. HIV·2026
    Same author

    Association Between <i>JAK2</i> V617F Somatic Mutation and Thoracic Aortic Aneurysms.

    Genes·2026
    Same author

    Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

    medRxiv : the preprint server for health sciences·2026
    Same author

    T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

    medRxiv : the preprint server for health sciences·2026
    Same journal

    Aging and HIV: a conversation with Dr. Glenn Treisman. Interview by Jennifer Heflin.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    Same journal

    HIV/HCV coinfection: a new era of treatment.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    Same journal

    Making sense of side effects.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    Same journal

    Rilpivirine and complera: new first-line treatment options.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    Same journal

    Becoming a positive parent: reproductive options for people with HIV.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    Same journal

    Giving advocates a voice: an update on the U.S. Positive Women's Network. Interview by Jennifer Heflin.

    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
    See all related articles

    Area of Science:

    • HIV/AIDS research
    • Infectious diseases
    • Pharmacology

    Background:

    • Salvage therapy is initiated when standard anti-HIV treatments fail to maintain undetectable viral load, CD4 counts above 200 cells/mm3, and prevent disease progression.
    • This therapeutic approach presents significant challenges for both patients and healthcare providers due to the complexity of managing treatment-experienced individuals.
    • The definition of salvage therapy varies, ranging from post-first-line regimens to situations involving extensive multi-drug resistance.

    Discussion:

    • Understanding the nuances of salvage therapy is crucial for effective HIV management.
    • Cross-resistance within drug classes can limit treatment options for individuals with HIV.
    • The concept of salvage therapy exists on a spectrum, from managing experienced patients to end-of-the-line treatment scenarios.

    Related Experiment Videos

    Key Insights:

    • Salvage therapy represents a vital strategy for patients with treatment-experienced HIV.
    • Effective management requires a clear understanding of the patient's treatment history and resistance profile.
    • The article provides relevant information for any patient altering their HIV drug regimen.

    Outlook:

    • Further research into novel drug combinations and treatment strategies is essential for salvage therapy.
    • Personalized medicine approaches may improve outcomes for individuals requiring salvage therapy.
    • Continued development of antiretroviral drugs is critical to overcome evolving HIV resistance.